| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
53 |
53 |
$4K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
27 |
27 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
99 |
91 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
53 |
53 |
$712.50 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
31 |
31 |
$549.47 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
31 |
31 |
$549.47 |
| G0008 |
Administration of influenza virus vaccine |
47 |
47 |
$493.70 |
| T1015 |
Clinic visit/encounter, all-inclusive |
51 |
47 |
$415.80 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12 |
12 |
$213.08 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
13 |
$74.16 |
| 81025 |
|
20 |
19 |
$61.80 |
| 36415 |
Collection of venous blood by venipuncture |
50 |
49 |
$52.20 |
| 81003 |
|
12 |
12 |
$27.56 |
| 90656 |
|
73 |
73 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
28 |
14 |
$0.00 |